Using a thorough supplier risk assessment during DFM is critical in creating a robust supply chain that can prevail in ideal conditions and non-ideal environments like the present day.
Winfried Schaller tells how the company prioritized its planned investments, what they're hearing from orthopedic device companies and lessons learned throughout the pandemic.
BioDur® nickel- and cobalt-free stainless steel alloy has been identified for use in implantable medical devices and surgical instruments. Additionally, the material can be additively manufactured.
Long before the pandemic began, the President and CEO of The Orthopedic Implant Company was hard at work pioneering a more affordable and transparent way to distribute implants. We interviewed Itai Nemovicher on the company's new initiative and his leadership philosophy.
Suppliers have bolstered their vendor managed inventory services, providing OEMs product flexibility and transparency. Elite-Medical, Micropulse and Millstone discuss what they expect for the next five years.
Upcoming Webinar | September 16, 2020, 11:00 am EST
Learn about Additive Manufacturing for Orthopedics and take a closer look at supply chain considerations. Learn about the efficiency of EBM vs. laser for acetabular cups. We discuss the use of software to digitally add roughness to a part when clinical relevance is already part of the process. Register
Despite the uncertainty brought on by COVID-19, we’ve looked ahead and developed our orthopedic market forecasts through 2022. This data and a full look at the orthopedic market is available for download now in THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®.
COVID-19 has created much uncertainty for the industry's forecast. We’re planning for disruption to procedure volumes and day-to-day business to last through 2020 and into 2021.
The two entities will form MW Industries Life Sciences. Toby Buck, former CEO and Chairman of Paragon Medical, will serve as President of the division upon the transaction's close in 4Q20.
This session provides examples of the updated DF(x) approach in action and highlights its impact on the design process, departmental relationships and the business. You will learn how DF(x) benefits the design process while quantifying and eliminating waste. Register
A smart legal strategy is to develop a comprehensive intellectual property portfolio of the various diverse—but related—IP rights associated with the inventive device.
Leadership must foster a culture of business and quality equilibrium to drive long-term success. Such commitment involves proper planning, employee training and performance measurement.
